While it may seem like there are new drugs coming on the market all of the time, that is not the case with the class of drugs for the treatment of heart failure. In fact, the last time the FDA approved a heart failure drug was in 2005. However, cardiologists now have a new reason to get excited about the treatment of heart failure patients with the FDA-approval of LCZ696, also known as Entresto, last month.
After disappointing results from previous drugs in development, Entresto demonstrated reduced heart failure deaths and reduced hospitalizations due to heart failure in the... Read More »